Ethics poll of Canadian MDs finds strongly held viewsBig responses seen for right to not offer procedures due to religious beliefs and condemning deception ‘in patient’s best interest’ LETTER: Another view on pharma rep detailing Clinical In Brief Infanrix hexa: new combined vaccine for infants GlaxoSmithKline is introducing Infanrix hexa. Detailed discharge plan reduces returns to hospital Implementing standardized process of patient education could improve outcomes and save health-care system money Cough and cold medicines should not be given to children under six Children under six years of age should not be given over-the-counter (OTC) cough and cold medication, a new Health Canada advisory said. Botox not the first choice, but still good for muscle spasm B.C. government and BCPhA announce drug-pricing agreement B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy. New pediatric indication for Reyataz Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age. Phase 1 of Alberta's new Pharmaceutical Strategy introduced Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8. First Previous 1260 1261 1262 1263 1264 Next Last
